🇺🇸 FDA
Patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

granted A61KA61K38/00A61P

Quick answer

US patent 7339037 (Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P31/12, A61P31/16